/
Other
Prostatectomy
12
Pipeline Programs↗
12
Active Trials↗
14
Companies Involved↗
Prostatectomy is an emerging landscape with 12 programs across 14 companies. The most active players are SURGE Therapeutics. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical5
Phase 11
Approved
No programs
Analysis
Trial Status
64
clinical trials
Completed32 · 50%
Unknown status9 · 14%
Active, not recruiting7 · 11%
Recruiting5 · 8%
Withdrawn5 · 8%
Terminated5 · 8%
Other1 · 2%
Clinical Trials
Trial Activity
64 trials
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
Recruiting·—·Phase 3·NCT07427043·300 enrolled
A Randomized Non-Inferiority Trial Comparing Two Training Modalities for Achieving Proficiency in Robot-Assisted Radical Prostatectomy
Recruiting·—·Preclinical·NCT07669974·56 enrolled
The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Following Radical Prostatectomy
Completed·—·N/A·NCT01317368·75 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)